Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8777700 | Early Human Development | 2018 | 8 Pages |
Abstract
Buprenorphine exposure during pregnancy can alter neonatal neurobehavioral and physiological responses to stimuli. A systematic evaluation of the newborn's functional domains above NAS assessment alone is crucial to address the challenges created by neurobehavioral dysregulation associated with substance exposure, improve caregiver/infant interaction and developmental trajectory. Comprehensive pre/postnatal treatment of buprenorphine-maintained mothers can lead to healthier outcomes for the dyad.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Martha L. Velez, Krystle McConnell, Nancy Spencer, Lina Montoya, Michelle Tuten, Lauren M. Jansson,